Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis

Journal of Surgical Research

Volumn 168, Issue 1, 2011, Pages 149-154

  Esemuede, Nowokere ^a   Lee, Taeseung ^a   Maier, Kristopher G ^c,d   Sumpio, Bauer E ^a,b   Gahtan, Vivian ^a,b,c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^d VA Healthcare Network Upstate New York   (United States)

Author keywords

chemotaxis; migration; Ras; Rho; statin; vascular smooth muscle

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; GERANYLGERANYL TRANSFERASE INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; LACTATE DEHYDROGENASE; MEVALONIC ACID; MEVINOLIN; RAS PROTEIN; THROMBOSPONDIN 1; TRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY TEST; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE CELL CHEMOTAXIS; WESTERN BLOTTING;

ANIMALS; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MEVALONIC ACID; MODELS, ANIMAL; MONOMERIC GTP-BINDING PROTEINS; MUSCLE, SMOOTH, VASCULAR; RAS PROTEINS; SIGNAL TRANSDUCTION; THROMBOSPONDIN 1; TUNICA INTIMA; TUNICA MEDIA;

EID: 79955577371     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.11.728     Document Type: Article

References (29)

1. Baenziger NL, Brodie GN, Majerus PW. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci USA 1971;68:240.
2. Raugi GJ, Mullen JS, Bark DH, et al. Thrombospondin deposition in rat carotid artery injury. Am J Path 1990;137:170.
3. Gahtan V, Wang XJ, Ikeda M, et al. Thrombospondin-1 induces activation of focal adhesion kinase in vascular smooth muscle cells. J Vasc Surg 1999;29:1031.
4. Willis AI, Fuse S, Wang XJ, et al. Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis. J Vasc Surg 2000;31:1160.
5. Gahtan V, Wang XJ, Willis AI, et al. Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent. Surgery 1999;126:203.
6. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383.
7. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. NJM 1995;333:1301.
8. Vaughan CJ, Gotto AM, Basson CT. The evolving role of statins in the management of atherosclerosis. JACC 2000;35:1.
9. Liao JK, Takemoto M. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 2001;21:1712.
10. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425.
11. Casey PJ. Biochemistry of protein prenylation. J Lipid Res 1992;33:1731.
12. Willis AI, Wang XJ, Kito H, et al. Ras N17 transfection inhibits TSP-1-induced VSMC migration. Surgical Forum 1999; L:454.
13. Soma MR, Donetti E, Parolini C, et al. HMG CoA Reductase Inhibitors In Vivo effects on carotid intimal hyperplasia in normocholesterolemic rabbits. Arteriosclerosis and Thrombosis 1993;13:571.
14. Sparrow CP, Burton CA, Hernandez M, et al. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol 2001;21:115.
15. Riessen R, Axel DI, Fenchel M, et al. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells. Basic Res Cardiol 1999;94:322.
16. Endres M, Laufs U, Huang Z, et al. Stroke protection by 3-hydroxy- 3-methylglutaryl-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1998;95:8880.
17. Muniyappa R, Xu R, Ram JL, et al. Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2000;278:H1762.
18. Kip1. J Biol Chem 1999;274:21926.
19. Llorente-Cortes V, Martinez-Gonzalez J, Badimon L. Esterified cholesterol accumulation induced aggregated uptake in human vascular smooth cells is reduced by HMG-CoA reductase inhibitors. Arterioscler Thromb Vasc Biol 1998;18:738.
20. Corsini A, Bernini F, Quarato P, et al. Non-lipid related effects 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Cardiology 1996;87:458.
21. Corsini A, Raiteri M, Soma MR, et al. Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Am J Cardiol 1995;76:21A.
22. Hidaka Y, Eda T, Yonemoto M, et al. Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733). Atherosclerosis 1992;95:87.
23. Wong B, Lumma WC, Smith AM, et al. Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranylgeranylation. J Leukoc Biol 2001;69:959.
24. Jakobisiak M, Bruno S, Skierski JS, et al. Cell cycle specific effects of lovastatin. Proc Natl Acad Sci USA 1991;88:3628.
25. Johnson MD, Woodard A, Okediji EJ, et al. Lovastatin is a potent inhibitor of meningioma cell proliferation: Evidence for inhibition of a mitogen associated protein kinase. J Neuro-Oncology 2002;56:133.
26. Sindermann J, Schmidt A, Breithardt G, et al. Lovastatin controls signal transduction in vascular smooth muscle cells by modulating phosphorylation levels of mevalonate- independent pathways. Basic Res Cardiol 2001;96:283.
27. Negre-Aminou P, Van Erck M, Van Leeuwen R, et al. Differential effect of simvastatin on various signal transduction intermediates in cultured human smooth muscle cells. Biochem Pharm 2001;61:991.
28. Takata M, Urakaze M, Temaru R, et al. Pravastatin suppresses the interleukin-8 production induced by thrombin in human endothelial cells cultured with high glucose by inhibiting the p44/42 mitogen activated protein kinase. Br J Pharm 2001;134:753.
29. Orr AW, Pallero MA, Xiong WC, et al. Thrombospondin induces RhoA inactivation through FAK-dependent signaling to stimulate focal adhesion disassembly. J Biol Chem 2004;279:48983.